Preparation of EGFR monoclonal antibody conjugated nanoparticles and targeting to hepatocellular carcinoma

Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib

Thomas J. Lynch, Daphne W. Bell, Raffaella Sordella et al. · New England Journal of Medicine · 2004 · 11.5K citations

Medicine, Oncology, Pharmacology +16

Drug Delivery Systems: Entering the Mainstream

Theresa M. Allen, Pieter R. Cullis · Science · 2004 · 4.5K citations

Pharmacy, Pharmaceutics, Pharmacology +17

Epidermal growth factor receptor overexpression correlates with a poor prognosis in completely resected non-small-cell lung cancer

Giovanni Selvaggi, Silvia Novello, Valter Torri et al. · Annals of Oncology · 2003 · 293 citations · Full text

Medicine, Oncology, Pathology +11

Targeting and imaging cancer cells by Folate-decorated, quantum dots (QDs)- loaded nanoparticles of biodegradable polymers

Jie Pan, Si‐Shen Feng · Biomaterials · 2008 · 234 citations

Pharmacy, Molecular Pharmaceutics, Pharmaceutics +17

Highly Specific HER2-mediated Cellular Uptake of Antibody-modified Nanoparticles in Tumour Cells

Heidrun Wartlick, Kerstin Michaelis, Sabine Balthasar et al. · Journal of drug targeting · 2004 · 212 citations

Pharmacy, Oncology, Pharmaceutics +17